BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 18410554)

  • 1. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best?
    Arshad MF; McAllister J; Merchant A; Rab E; Cook J; Eastell R; Balasubramanian S
    Postgrad Med J; 2021 Sep; 97(1151):577-582. PubMed ID: 32892159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hypocalciuric hypercalcaemia: a review.
    Christensen SE; Nissen PH; Vestergaard P; Mosekilde L
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):359-70. PubMed ID: 21986511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of calcium excretion and calcium/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Bhangu JS; Selberherr A; Brammen L; Scheuba C; Riss P
    Head Neck; 2019 May; 41(5):1372-1378. PubMed ID: 30554440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing pre-operative urinary calcium excretion in primary hyperparathyroidism.
    Kaderli RM; Riss P; Geroldinger A; Selberherr A; Scheuba C; Niederle B
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):97-102. PubMed ID: 28383779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia.
    Bertocchio JP; Tafflet M; Koumakis E; Maruani G; Vargas-Poussou R; Silve C; Nissen PH; Baron S; Prot-Bertoye C; Courbebaisse M; Souberbielle JC; Rejnmark L; Cormier C; Houillier P
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2534-2542. PubMed ID: 29727008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
    Shinall MC; Dahir KM; Broome JT
    Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the urine calcium-to-creatinine ratio to diagnose primary hyperparathyroidism in asymptomatic hypercalcaemic patients with vitamin D deficiency.
    Jayasena CN; Mahmud M; Palazzo F; Donaldson M; Meeran K; Dhillo WS
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):126-9. PubMed ID: 21303875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):798-807. PubMed ID: 19250271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study.
    Isaksen T; Nielsen CS; Christensen SE; Nissen PH; Heickendorff L; Mosekilde L
    Calcif Tissue Int; 2011 Oct; 89(4):285-94. PubMed ID: 21785908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene.
    Felderbauer P; Karakas E; Fendrich V; Bulut K; Werner I; Dekomien G; Klein W; Bartsch D; Schmidt WE
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):527-9. PubMed ID: 17853337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excluding familial hypocalciuric hypercalcaemia before surgery for primary hyperparathyroidism - a practical evaluation of urinary calcium using a retrospective cohort design.
    McAllister J; Arshad MF; Rab E; Balasubramanian SP
    Ann R Coll Surg Engl; 2022 Nov; 104(9):710-716. PubMed ID: 35446160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
    Sumida A; Iizuka K; Kato T; Liu Y; Kubota S; Kubota-Okamoto S; Sakurai T; Imaizumi T; Takahashi Y; Mizuno M; Takao K; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Seino Y; Suzuki A; Yabe D
    BMC Endocr Disord; 2022 Jun; 22(1):164. PubMed ID: 35733207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
    BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.
    Ward BK; Magno AL; Blitvich BJ; Rea AJ; Stuckey BG; Walsh JP; Ratajczak T
    Clin Endocrinol (Oxf); 2006 May; 64(5):580-7. PubMed ID: 16649980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.